Published in Ann Rheum Dis on June 01, 1976
Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax (2001) 2.74
Airways obstruction in rheumatoid arthritis. Ann Rheum Dis (1979) 1.31
Systemic lupus erythematosus and pulmonary manifestation. Ann Rheum Dis (1980) 0.75
AUTO-ANTIBODY STUDIES IN INTERSTITIAL PULMONARY FIBROSIS. Br Med J (1965) 3.17
Lung lesions in rheumatoid arthritis. Br Med J (1955) 3.03
Pulmonary dysfunction in rheumatoid disease. Chest (1973) 2.84
Possible relationship of rheumatoid factors and pulmonary disease. Am J Med (1962) 2.24
The pleural and pulmonary complications of rheumatoid arthritis. Ann Intern Med (1959) 1.74
PULMONARY INVOLVEMENT IN RHEUMATOID ARTHRITIS. JAMA (1964) 1.37
Comparison of pulmonary function in patients with systemic lupus erythematosus, scleroderma, and rheumatoid arthritis. Am Rev Respir Dis (1966) 1.35
RHEUMATOID LUNG DISEASE. Ann Intern Med (1965) 1.35
Lung function in rheumatoid arthritis. A clinic survey. Ann Rheum Dis (1974) 1.29
Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis. Ann Rheum Dis (1969) 1.24
Respiratory function in systemic lupus erythematosus, scleroderma, and rheumatoid arthritis. Ann Rheum Dis (1973) 1.19
PULMONARY DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS. JAMA (1964) 1.16
STUDIES OF RHEUMATOID PULMONARY DISEASE. A COMPARISON OF ROENTGENOLOGICAL FINDINGS AMONG PATIENTS WITH HIGH RHEUMATOID FACTOR TITERS AND WITH COMPLETELY NEGATIVE REACTIONS. Acta Tuberc Pneumol Scand (1964) 1.01
Interstitial rheumatoid lung disease. A reassessment and review of the literature. Chest (1972) 1.00
PULMONARY DYSFUNCTION IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS. Dis Chest (1964) 0.95
[Respiratory disorders in the course of chronic rheumatoid arthritis]. Poumon Coeur (1973) 0.92
Positive antinuclear factor in patients with unexplained pulmonary fibrosis. Ann Intern Med (1969) 0.91
[Diffusion disorders in primary chronic polyarthritis and lupus erythematosus disseminatus]. Beitr Klin Erforsch Tuberk Lungenkr (1970) 0.88
[Pulmonary lesions in chronic arthritis and lupus erythematosus disseminatus (author's transl)]. Radiologe (1974) 0.79
[Pulmonary manifestations of systemic diseases]. Nord Med (1961) 0.79
[Pulmonary function and rheumatoid arthritis]. Z Rheumatol (1976) 0.78
SHEEP CELL AGGLUTINATION TEST IN CHRONIC INTERSTITIAL PULMONARY FIBROSIS. Ann Rheum Dis (1965) 0.78
Rheumatology and the lungs. J Am Geriatr Soc (1968) 0.78
[Pulmonary radiographic lesions in 330 cases of rheumatoid arthritis as compared with 330 controls]. Rev Rhum Mal Osteoartic (1972) 0.78
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62
Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia (1992) 2.72
Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia (1983) 2.18
Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost (1994) 2.09
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab (2014) 1.99
Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes (2009) 1.65
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes Obes Metab (2014) 1.51
Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev (2008) 1.50
Patients with chronic obstructive pulmonary disease (COPD): their veins and pulmonary embolization. Respiration (1998) 1.49
Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum (1989) 1.48
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol (2003) 1.44
The effect of screw size and insertion technique on the stability of the mandibular sagittal split osteotomy. J Oral Maxillofac Surg (1994) 1.43
Old versus new: nitroglycerin versus NO? Respiration (1998) 1.41
Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol (1980) 1.41
[Lispro-insulin analogs in therapy of diabetes]. Wien Klin Wochenschr (1997) 1.40
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
Pemphigus erythematosus-like rash in a patient on penicillamine. Br Med J (1977) 1.39
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
Stress fractures of the femoral neck. Clin Orthop Relat Res (1998) 1.27
Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia (1988) 1.23
CADIAG: approaches to computer-assisted medical diagnosis. Comput Biol Med (1985) 1.19
Demonstration of antibodies to collagen and of collagen-anticollagen immune complexes in rheumatoid arthritis synovial fluids. Ann Rheum Dis (1975) 1.19
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev (2005) 1.18
[Autoimmune phenomena in D-penicillamine therapy]. Acta Med Austriaca (1975) 1.17
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med (2005) 1.17
Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med (1995) 1.14
Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int (2005) 1.11
Basicervical fractures of the proximal femur. A biomechanical study of 3 internal fixation techniques. Clin Orthop Relat Res (1994) 1.11
Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus. Metabolism (1984) 1.10
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) (2005) 1.08
Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia (1976) 1.08
Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med (1979) 1.06
Investigations into the fat pads of the sole of the foot: anatomy and histology. Foot Ankle (1992) 1.05
Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia (2011) 1.03
HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. J Rheumatol (1984) 1.02
Thrombin generation in morbid obesity: significant reduction after weight loss. J Thromb Haemost (2010) 1.02
Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. Diabete Metab (1986) 1.01
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer (1990) 1.00
Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol (2003) 1.00
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria. Diabet Med (2007) 0.99
Investigations into the fat pads of the sole of the foot: heel pressure studies. Foot Ankle (1992) 0.99
Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay. Arthritis Rheum (1978) 0.99
Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care (1985) 0.98
[Austrian Society for Lung Diseases and Tuberculosis: Consensus on diagnosis and therapy of bronchial asthma in adults. Revised draft 1999]. Wien Klin Wochenschr (1999) 0.97
Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res (2001) 0.97
Letter: Serum beta2-microglobulin and SLE. Arthritis Rheum (1976) 0.96
Natural killer cell activity and antibody-dependent cellular cytotoxicity in patients under various immunosuppressive regimens. Clin Immunol Immunopathol (1987) 0.95
Bronchoalveolar lavage in rheumatoid arthritis. Br J Rheumatol (1993) 0.95
Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia (2008) 0.95
The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary-failure to sulfonylureas. A five year follow-up study. Horm Metab Res (1992) 0.95
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant (2014) 0.94
Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia (1998) 0.94
Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis. Arthritis Rheum (1980) 0.94
67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes. Eur J Nucl Med (1982) 0.94
Ia-Type alloantigens and humoral autoimmune responsiveness in insulin-dependent diabetes mellitus. Metabolism (1979) 0.92
The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab (2008) 0.92
HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum (1980) 0.92
Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. Eur J Clin Invest (2006) 0.91
Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) (1992) 0.91
Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia (1985) 0.91
HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. J Clin Endocrinol Metab (1983) 0.91
Relative hypoleptinaemia in women with mild gestational diabetes mellitus. Diabet Med (1999) 0.91
[Development of pulmonary function following operations for skoliosis]. Z Orthop Ihre Grenzgeb (1972) 0.90
HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis (1987) 0.90
Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care (1989) 0.90
Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 0.90
Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients. Eur J Clin Pharmacol (1986) 0.90
Surface damage to an Oxinium femoral head prosthesis after dislocation. J Bone Joint Surg Br (2007) 0.89
Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care (1997) 0.89
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia (1991) 0.89
[Scoliosis and lung function]. Z Orthop Ihre Grenzgeb (1970) 0.89
Peripheral insulin resistance in primary hyperparathyroidism. Metabolism (1983) 0.88
Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens (1996) 0.88
Impact of peripheral arterial disease in patients with diabetes--results from PROactive (PROactive 11). Atherosclerosis (2008) 0.88
Sensitivity of platelets to prostaglandins in cornary heart disease and angina pectoris. Prostaglandins (1981) 0.88
Glycosylated haemoglobin in renal failure. Diabetologia (1980) 0.88
Histology and histomorphometric analysis of the normal and atrophic heel fat pad. Foot Ankle Int (1995) 0.88
The importance of HLA genes to susceptibility in the development of juvenile diabetes mellitus. A study of 93 patients and 68 first degree blood relations. Diabete Metab (1977) 0.87
[High dosage vitamin E therapy in patients with activated arthrosis]. Z Rheumatol (1991) 0.87
Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes. Eur J Clin Invest (2004) 0.87
The effect of arm position and capsular release on rotator cuff repair. A biomechanical study. J Bone Joint Surg Br (1991) 0.87
[Islet-cell antibodies in juvenile diabetes mellitus (author's transl)]. Dtsch Med Wochenschr (1977) 0.86
Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery (1987) 0.86
The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity. Int J Obes (Lond) (2012) 0.86
Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res (1990) 0.86
Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care (1995) 0.85
[The respiratory function and clinical condition of patients after severe thoracic trauma]. Unfallheilkunde (1976) 0.85
Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop (Belle Mead NJ) (1999) 0.85
Immunoglobulin G-insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1979) 0.85
Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: correlation with clinical and immunological parameters. Rheumatol Int (1981) 0.85
HLA-DR antigens and disease patterns of rheumatoid arthritis. Rheumatol Int (1983) 0.84
Antefemoral dissecting cysts in rheumatoid arthritis. Radiology (1979) 0.84